Acucela Announces Experimental Eye Research Publication; Paper Outlines First Demonstrated Effect of Visual Cycle Modulation Treatment on Retinopathy

Dr. Ryo Kubota, Acucela President and CEO, a Co-Author with
Colleagues at Children's Hospital and Harvard Medical of These
Significant Findings
BOTHELL, Wash.--(BUSINESS WIRE)--Aug 9, 2010 - Acucela, a
clinical-stage biotechnology company...